Akebia Therapeutics
Clinical trials sponsored by Akebia Therapeutics, explained in plain language.
Biopharmaceutical company focused on kidney disease treatments.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New anemia pill for dialysis patients tested against standard shots
Disease control OngoingThis study tests a new pill, vadadustat, taken three times a week, against the usual injected medicine for anemia in people with kidney failure who are on dialysis. About 350 adults will take part to see if the pill can safely keep their red blood cell levels in a healthy range. …
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Kidney anemia pill for kids pulled before starting
Disease control TerminatedThis study planned to test a daily pill called vadadustat for anemia in children with chronic kidney disease. It aimed to see if the pill could safely replace standard injections. However, the trial was withdrawn before enrolling any participants, so no results are available.
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Kidney anemia pill study for kids pulled before it started
Disease control TerminatedThis study was designed to test a once-daily pill called vadadustat for treating anemia in children with chronic kidney disease. The goal was to see if the drug could safely raise red blood cell levels without the need for injections. However, the study was withdrawn before enrol…
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC